Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

360
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
360
Analgesia and Pain Management01:25

Analgesia and Pain Management

696
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
696
Drug Therapy01:28

Drug Therapy

82
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
82
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

802
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
802
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

312
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
312
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

584
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
584

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation modeling of neighborhood-level differences in life course health outcomes: a proof of concept.

Innovation in aging·2026
Same author

From Co-Design to Quality Improvement: Using the Double Diamond Framework to Develop Primary Care Redesign Priorities for Hypertension Care.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

A Theoretically Grounded Chronic Illness Model Integrating Medical- and Community-Based Social Service Providers.

Population health management·2026
Same author

Factors Influencing Quality Improvement Success in Primary Care: A Comparative Case Study of High- and Low-Performing Sites in Patient Hypertension Outcomes.

Journal of the American Heart Association·2026
Same author

Heart Healthy Ohio Initiative: A Statewide Cooperative to Improve Cardiovascular Risk.

Journal of general internal medicine·2026
Same author

Beyond Clinical Competence: Preparing Psychiatry Trainees for Leadership in Complex Systems.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2025

Related Experiment Video

Updated: Aug 6, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K

Increasing Primary Care Utilization of Medication-Assisted Treatment (MAT) for Opioid Use Disorder.

Stacey L Gardner-Buckshaw1, Adam T Perzynski2, Russell Spieth2

  • 1From the Department of Family and Community Medicine, Northeast Ohio Medical University (SGB); Center for Health Care Research and Policy within The MetroHealth System, Case Western Reserve University, Cleveland, OH (ATP); Adult Behavioral Health, The Centers, Cleveland, OH (RS); Department of Psychiatry, The MetroHealth System, Cleveland, OH (PK); Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH (CDR); Summa Health, Barberton Family Medicine Residency Program, Cleveland, OH (LN); Department of Family and Community Medicine, Northeast Ohio Medical University, Rootstown, OH (DK); Center for Health Care Research and Policy within The MetroHealth System, Case Western Reserve University (AC); Department of Family and Community Medicine, Northeast Ohio Medical University (JMB). sgardnerbuckshaw@neomed.edu.

Journal of the American Board of Family Medicine : JABFM
|March 22, 2023
PubMed
Summary

Primary care providers (PCPs) showed increased confidence and willingness to treat opioid use disorder (OUD) after a supplemental Medication-Assisted Treatment (MAT) training program. This training addresses a critical gap in addiction care for PCPs.

Keywords:
Disease ManagementMedication-Assisted TreatmentNarcoticsOpioid-Related DisordersPhysicians

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.7K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.2K

Related Experiment Videos

Last Updated: Aug 6, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.7K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.2K

Area of Science:

  • Medical Education
  • Addiction Medicine
  • Primary Care Practice

Background:

  • Increasing prevalence of opioid use disorders (OUDs) necessitates primary care providers (PCPs) trained in addiction treatment.
  • Physicians often lack adequate training to manage patients with addiction, leading to underpreparedness.
  • A specialized Medication-Assisted Treatment (MAT) training program was developed for PCPs to address this gap.

Purpose of the Study:

  • To evaluate the effectiveness of a supplemental MAT training program for PCPs.
  • To assess changes in PCPs' knowledge, skills, and attitudes regarding MAT implementation.
  • To increase PCP likelihood of implementing MAT by addressing reported barriers.

Main Methods:

  • A 4-hour buprenorphine office-based implementation training was designed to supplement existing SAMHSA DATA 2000 waiver training.
  • A new pre- and post-survey instrument was developed and validated to assess changes in participants.
  • Data were analyzed using REDCap to determine pre-post differences in confidence, competence, and willingness.

Main Results:

  • 183 participants completed pre-post evaluations, showing substantial improvements.
  • PCPs reported significantly higher confidence in implementing MAT care processes and interacting with MAT patients.
  • Participants demonstrated increased comfort, competence, and willingness to identify and treat patients with OUD using MAT.

Conclusions:

  • The supplemental MAT training program significantly enhances PCP confidence and willingness to implement addiction treatment.
  • This training addresses a critical need for improved primary care management of opioid use disorders.
  • Further research is warranted to replicate findings and inform policy recommendations for MAT expansion.